NERV
Minerva Neurosciences Inc
3.30$
+1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +90,030.7% | -99.9% | -8.4% | -7.5% | -13.2% | -11.7% | -7.3% | -7.7% | +248.7% | -4.0% | +1.1% | |
| – | +86,996.5% | -99.9% | -11.8% | -11.1% | -20.3% | -19.5% | -13.3% | -16.3% | +538.2% | -4.8% | +0.8% | |
| – | +87,126.3% | -99.9% | -11.3% | -14.4% | -19.5% | -19.1% | -11.8% | -19.4% | +569.8% | -60.2% | -24.7% | |
| – | +87,126.3% | -99.9% | -11.3% | -14.4% | -19.5% | -19.1% | -11.8% | -19.4% | +569.8% | -5.0% | -3.7% | |
| – | +99,900.0% | -99.9% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -27.3% | -37.5% | -60.0% | – | – | – | – | – | – | – | – | |
| – | +102,522.0% | -99.9% | +4.2% | -29.0% | -2.6% | -1.4% | +0.9% | +0.2% | +280.9% | +45.8% | -14.8% | |
| – | +99,624.1% | -99.9% | +48.5% | +6.7% | -36.7% | -31.4% | +29.9% | +5.7% | -14.3% | +95.7% | -11.7% | |
| – | +129,307.1% | -99.9% | -42.3% | -33.2% | +190.6% | -60.2% | +40.1% | +5.3% | -32.3% | +231.1% | -31.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -14.0% | +16.3% | +0.0% | +0.0% | +0.0% | +0.0% | 0.0% | +0.0% | +46.9% | +294.9% | +80.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.